Immunovant Inc. Common Stock vs YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $39.54 (market cap $28.90M). The key difference: Immunovant Inc. Common Stock is far larger — about 229.1× YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF for 60 Days on average.
| IMVT | QDTY | |
|---|---|---|
Market Cap | $6.62B | $28.90M |
Volume | 1,131,364 | 22,657 |
Sector | Health | Income / Options Overlay |
52-Week High | $44.96 | $46.71 |
52-Week Low | $17.03 | $36.57 |
Typical Hold Time | 0 Days | 60 Days |
Enterprise Value | $5.72B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.
Read more on QDTY →